Tags

Type your tag names separated by a space and hit enter

Altitude illness: update on prevention and treatment.
Curr Sports Med Rep. 2012 May-Jun; 11(3):124-30.CS

Abstract

Altitude illness is a broad category of disease encompassing acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE) that can affect persons who travel to altitude without adequate acclimatization. Initial symptoms of AMS and the more serious HACE or HAPE can be subtle, and it is important that the practitioner be able to recognize and differentiate between these diagnoses because they can progress rapidly and be fatal if untreated. There are well-established criteria and many proven therapies both for prophylaxis and treatment of altitude illness; however, despite intense research efforts, the specific mechanisms of these complex diseases remain elusive. Adequate acclimatization via controlled ascent remains the most important factor in preventing altitude illness, although prophylactic pharmacotherapy also may be useful. Rapid descent remains the most important treatment factor, although treatment at altitude with various therapies is possible for mild cases with adequate resources.

Authors+Show Affiliations

Department of Family and Community Medicine, Eisenhower Army Medical Center, Fort Gordon, GA, USA.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22580489

Citation

Eide, Richard P., and Chad A. Asplund. "Altitude Illness: Update On Prevention and Treatment." Current Sports Medicine Reports, vol. 11, no. 3, 2012, pp. 124-30.
Eide RP, Asplund CA. Altitude illness: update on prevention and treatment. Curr Sports Med Rep. 2012;11(3):124-30.
Eide, R. P., & Asplund, C. A. (2012). Altitude illness: update on prevention and treatment. Current Sports Medicine Reports, 11(3), 124-30. https://doi.org/10.1249/JSR.0b013e3182563e7a
Eide RP, Asplund CA. Altitude Illness: Update On Prevention and Treatment. Curr Sports Med Rep. 2012 May-Jun;11(3):124-30. PubMed PMID: 22580489.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Altitude illness: update on prevention and treatment. AU - Eide,Richard P,3rd AU - Asplund,Chad A, PY - 2012/5/15/entrez PY - 2012/5/15/pubmed PY - 2012/10/24/medline SP - 124 EP - 30 JF - Current sports medicine reports JO - Curr Sports Med Rep VL - 11 IS - 3 N2 - Altitude illness is a broad category of disease encompassing acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE) that can affect persons who travel to altitude without adequate acclimatization. Initial symptoms of AMS and the more serious HACE or HAPE can be subtle, and it is important that the practitioner be able to recognize and differentiate between these diagnoses because they can progress rapidly and be fatal if untreated. There are well-established criteria and many proven therapies both for prophylaxis and treatment of altitude illness; however, despite intense research efforts, the specific mechanisms of these complex diseases remain elusive. Adequate acclimatization via controlled ascent remains the most important factor in preventing altitude illness, although prophylactic pharmacotherapy also may be useful. Rapid descent remains the most important treatment factor, although treatment at altitude with various therapies is possible for mild cases with adequate resources. SN - 1537-8918 UR - https://www.unboundmedicine.com/medline/citation/22580489/Altitude_illness:_update_on_prevention_and_treatment_ L2 - http://Insights.ovid.com/pubmed?pmid=22580489 DB - PRIME DP - Unbound Medicine ER -